Nirrin Technologies Establishes Scientific Advisory Board with Seasoned Leaders in Biomanufacturing and Advanced Therapeutic Development
Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the founding of its Scientific Advisory Board (SAB), with key experts in diverse fields across biomanufacturing and advanced therapeutic development joining as inaugural members.
NTx Announces Full Commercial Availability of NTxscribe to Broadly Enable RNA Therapies
Nature’s Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the full commercial availability of NTxscribe®, a benchtop, continuous flow RNA in vitro transcription (IVT) and purification system that brings cost effective and scalable RNA manufacturing to the market.
South 8 Awarded $1.6M U.S. Army Contract to Prototype Military Battery Packs for Extreme Climates
South 8 Technologies (South 8), the developer of LiGas®, a liquefied gas electrolyte for advanced lithium-ion batteries, announced today that the U.S. Army Combat Capabilities Development Command (DEVCOM) C5ISR Center has awarded a $1.6 million contract to a team of companies led by South 8 to demonstrate standardized lithium-ion battery packs for defense applications. South 8 is partnering with a battery cell manufacturer and a leading vendor of battery packs to deliver prototypes that will offer a broad operating temperature range and high performance in extreme cold environments to the U.S. Army.
BioSkryb Genomics Launches ResolveSEQ MRD: A Next-Generation Measurable Residual Disease (MRD) Discovery Solution
BioSkryb Genomics, a pioneer in single-cell and ultra-low input multiomics is excited to announce the launch of ResolveSEQ MRD, an innovative service offering designed to empower further classification and characterization of the MRD cells for hematologic malignancies. ResolveSEQ MRD integrates seamlessly with established flow cytometry (FC) protocols to provide unparalleled single-cell genome and transcriptome characterization, offering deeper biological insights to drive greater discoveries in precision oncology.
EnCharge AI CEO Dr. Naveen Verma Honored with 2024 Edison Patent Award for Computing Innovation
In recognition for the foundational “Configurable In-Memory Computing Engine” patent that powers EnCharge AI’s core technology, CEO Dr. Naveen Verma has received the 2024 Edison Patent Award in Computing Technology from the Research & Development Council of New Jersey, the highest recognition of innovation in the state. Dr. Verma accepted this award during a ceremony and reception on November 21, 2024, at Bell Works in Holmdel, NJ. An announcement video is available here.
GelSight Extends Life and Durability of GelSight Mini with New Gels
GelSight, a pioneer in tactile intelligence technology, today announced the availability of updated gel for its GelSight Mini tactile sensor. The new gel offers up to 40 percent increased durability based on internal testing, with the same look and feel of the existing gels.
GelSight Delivers Automated Image Stitching and New 2D Measurement Tools on Any Material. Anywhere™
GelSight Mobile™ 4.0 Software Release fulfills top customer requests with new and improved capabilities
Former HOMER Energy CEO and Founder Peter Lilienthal Joins Xendee as an Advisor
With more than 40 years of international experience in the design and the economic and financial analysis of hybrid renewable and microgrid projects, Peter Lilienthal brings knowledge and insight to the Xendee team to help develop Xendee’s international presence in areas such as Africa, Asia-Pacific, and other emerging markets around the world.
NTx Secures $15M in Venture Debt from J.P. Morgan to Fuel Expansion of Next-Generation Biomanufacturing Solutions
The financing will support the adoption of NTx distributed biomanufacturing systems and development of end-to-end domestic supply chain for critical biomaterials
Cybersecurity Icon Michael Coden Elected to Board of Directors as Opscura Continues Rapid Expansion
Further Accelerating its Growth Plan, Opscura Appoints Michael Coden to Support Industrial and Building Automation Security Strategy